Skip to Content
  • Previous Rank831
  • Revenues ($M)$3,047.6
  • Revenue Percent Change22.5%
  • Profits ($M)$2,096.9
  • Profits Percent Change695.8%
  • Assets ($M)$6,245.9
  • Employees2,500
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Jeffrey M. Leiden
CEO Title
Chairman, President & Chief Executive Officer
Health Care
HQ Location
Boston, Mass.
Years on Fortune 500 List-

Vertex Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$3,047.622.5%
Profits ($M)$2,096.9695.8%
Assets ($M)$6,245.9-
Total Stockholder Equity ($M)$4,435.2-

Profit Ratios

Profit as % of Revenues68.8%
Profits as % of Assets33.6%
Profits as % of Stockholder Equity47.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)8.09
EPS % Change (from 2017)677.9%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2018)10.6%
Total Return to Investors (5 year, annualized)17.4%
Total Return to Investors (10 year, annualized)18.5%